CHEK1 and lung cancer: Our CHK1 phosphorylation studies revealed that the presence of caffeine caused a decrease of cisplatin-induced CHK1 phosphorylation at Ser317/Ser345 in both HTB182 and CRL5985 lung cancer cells, suggesting an inhibited ATR activity in these cells [17, 18].